Publications by authors named "N van Herwaarden"

Corticosteroids are often administered locally to prevent systemic exposure and side effects. It is not well known that all forms of locally administered corticosteroids can have systemic side effects. Because doctors are less aware of systemic side effects when using locally administered corticosteroids, these side effects are not always recognized and treated as such.

View Article and Find Full Text PDF

Objectives: To determine the effects of dose reduction of rituximab (RTX) on rheumatoid arthritis (RA) disease activity in clinical practice.

Methods: Retrospective cohort study of RA patients using RTX, in stable low disease activity (i.e.

View Article and Find Full Text PDF

Objective: Long-term gout management is based on reducing serum urate by using urate-lowering therapy (ULT). A lifelong treat-to-target approach is advocated, although a ULT (taper to) stop attempt can be considered (treat-to-avoid symptoms approach) during remission. Exploring the beliefs of patients with gout on long-term ULT strategies during remission is important for optimizing gout management.

View Article and Find Full Text PDF

Objectives: The Simple Erosion Narrowing Score (SENS) is a simplification of the Sharp/van der Heijde score (SHS). Previous studies found SENS and SHS to have very similar measurement properties, but suggest that SENS has a lower discriminative ability that may result in reduced power. Therefore, we aimed to quantify the effect of using SENS rather than SHS on the power to show between-group differences in radiographic progression.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the long-term safety and effectiveness of adjusting doses of TNF-inhibitors in rheumatoid arthritis patients based on disease activity over a 10-year period.
  • A total of 170 patients participated, with a significant reduction in the use of biological treatments and low disease activity maintained throughout the follow-up, evidenced by a mean DAS28-CRP score of 2.13.
  • The results showed that many patients could safely discontinue their treatment or reduce their dosage without major issues, with 74% successfully discontinuing their medication for a median time of 7 months.
View Article and Find Full Text PDF